PFE
Pfizer Inc. Healthcare - Pharmaceuticals Investor Relations →
Pfizer Inc. (PFE) closed at $26.97 as of 2026-03-20, trading 5.9% below its 200-week moving average of $28.67. This places PFE in the deep value zone. The stock moved further from the line this week, up from -7.6% last week. The 14-week RSI sits at 61, indicating neutral momentum.
Trading volume is running at 1.4x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.18 ratio) is neutral — neither side is clearly dominating.
Over the past 2759 weeks of data, PFE has crossed below its 200-week moving average 22 times. On average, these episodes lasted 39 weeks. Historically, investors who bought PFE at the start of these episodes saw an average one-year return of +11.8%.
With a market cap of $153.4 billion, PFE is a large-cap stock. The company generates a free cash flow yield of 8.8%, which is notably high. Return on equity stands at 8.9%. The stock trades at 1.8x book value.
Over the past 33.2 years, a hypothetical investment of $100 in PFE would have grown to $1542, compared to $2683 for the S&P 500. PFE has returned 8.6% annualized vs 10.4% for the index, underperforming the broader market over this period.
Free cash flow has been declining at a -29.6% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: PFE vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After PFE Crosses Below the Line?
Across 12 historical episodes, buying PFE when it crossed below its 200-week moving average produced an average return of -1.0% after 12 months (median -13.0%), compared to +10.9% for the S&P 500 over the same periods. 33% of those episodes were profitable after one year. After 24 months, the average return was +20.6% vs +19.2% for the index.
Each line shows $100 invested at the moment PFE crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
PFE has crossed below its 200-week MA 22 times with an average 1-year return of +11.8% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 1973 | Jun 1973 | 4 | 5.3% | -17.3% | +18372.0% |
| Nov 1973 | Dec 1973 | 4 | 9.4% | -23.2% | +17379.7% |
| Jan 1974 | Jan 1978 | 210 | 45.1% | -20.8% | +19531.2% |
| Feb 1978 | Mar 1978 | 4 | 3.1% | +23.0% | +24902.3% |
| Nov 1987 | Jan 1988 | 8 | 16.6% | +18.9% | +4784.0% |
| Feb 1988 | Feb 1988 | 1 | 0.2% | +20.2% | +4579.0% |
| May 1988 | May 1988 | 3 | 4.6% | +31.9% | +4534.3% |
| Jun 1988 | Sep 1988 | 12 | 4.0% | +15.7% | +4410.6% |
| Feb 1990 | Feb 1990 | 1 | 1.8% | +85.7% | +3776.4% |
| Apr 1990 | May 1990 | 1 | 0.7% | +109.4% | +3725.4% |
| Feb 1994 | May 1994 | 11 | 8.3% | +45.9% | +1615.0% |
| Jul 1994 | Jul 1994 | 1 | 0.9% | +57.9% | +1527.0% |
| Sep 2001 | Sep 2001 | 3 | 5.0% | -15.8% | +99.5% |
| Apr 2002 | Jan 2004 | 95 | 31.3% | -12.3% | +93.1% |
| Mar 2004 | Apr 2004 | 5 | 6.3% | -23.5% | +100.9% |
| Apr 2004 | Aug 2006 | 122 | 30.4% | -22.2% | +98.2% |
| Oct 2006 | Apr 2007 | 27 | 7.6% | -6.8% | +141.7% |
| Jun 2007 | Dec 2010 | 183 | 40.8% | -27.9% | +151.5% |
| Feb 2020 | Apr 2020 | 6 | 16.3% | +10.0% | +13.7% |
| Jun 2020 | Jul 2020 | 5 | 7.5% | +30.6% | +11.5% |
| Apr 2023 | Jun 2023 | 6 | 5.3% | -31.3% | -16.9% |
| Jun 2023 | Ongoing | 144+ | 36.7% | Ongoing | -16.5% |
| Average | 39 | — | +11.8% | — |
Frequently Asked Questions
Is PFE below its 200-week moving average?
Yes. As of 2026-03-20, Pfizer Inc. (PFE) is trading 5.9% below its 200-week moving average of $28.67. The current price is $26.97.
What is PFE's 200-week moving average price?
Pfizer Inc.'s 200-week moving average is $28.67 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when PFE drops below its 200-week moving average?
PFE has crossed below its 200-week moving average 22 times in our data. On average, buying at that moment produced a one-year return of +11.8%. These dips have historically been decent entry points. These episodes lasted 39 weeks on average.
Is PFE a good value right now?
Here's what our data says about PFE as of 2026-03-20: The stock is below its 200-week moving average, which is the starting point for our analysis. The 14-week RSI is 61. Free cash flow yield is 8.8%. Return on equity is 8.9%. Price-to-book is 1.8x. This is not a buy or sell recommendation — always do your own research.
How does PFE compare to the S&P 500?
Over the past 33.2 years, $100 invested in PFE would have grown to $1542, compared to $2683 for the S&P 500. That's 8.6% annualized vs 10.4% for the index. PFE has underperformed the broader market over this period.
Does PFE pay a dividend?
Yes. Pfizer Inc. currently pays a dividend yield of 638.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20